DEPO-MEDROL SUSPENSION INJECTABLE POUR CHIENS CHATS ET CHEVAUX
DEPO-MEDROL SUSPENSION INJECTABLE POUR CHIENS CHATS ET CHEVAUX
Authorised
- Methylprednisolone acetate
Product identification
Medicine name:
DEPO-MEDROL SUSPENSION INJECTABLE POUR CHIENS CHATS ET CHEVAUX
Active substance:
- Methylprednisolone acetate
Target species:
-
Dog
-
Cat
-
Horse
Route of administration:
-
Intramuscular use
-
Subcutaneous use
-
Intraarticular use
Product details
Active substance and strength:
-
Methylprednisolone acetate40.03/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intraarticular use
-
Horse
-
Meat and offal10day
-
Milkno withdrawal periodEn l’absence de détermination d’un temps d’attente pour le lait, ne pas utiliser chez les femelles productrices de lait de consommation, en lactation ou en période de tarissement ni chez les futures productrices de lait de consommation.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
- Pfizer Manufacturing Belgium
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/2370982 7/1992
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/09/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025